The kidney and drugs Flashcards
1
Q
Definition of renal clearance
A
The volume of plasma from which a substance is completely removed by the kidney in a given amount of time - ml/min
2
Q
Effect of urine pH on drug clearance
A
- Ionised drugs stay in the tubule
- pH urine 4.8-7.5
- Lipid soluble drugs are almost completely reabsorbed
- For an acidic drug, clearance rate is a lot lower with acidic urine than with alkaline urine
- For an alkaline drug, clearance rate is higher with acidic urine than with alkaline urine
3
Q
Half life of a drug and what is it dependent on
A
- It is the time necessary to halve the plasma concentration
- Dependent on:
1. Clearance: rate of drug elimination divided by plasma concentration
- Volume of distribution: fluid volume that would be required to contain the amount of drug present in the body at the same concentration as in the plasma
4
Q
Drugs and adverse renal effects (incl. examples):
- Antibiotics
- Chemotherapy
- NSAIDs
- ACE inhibitors
A
- Antibiotics cause tubular toxicity
- Aminoglycosides
- Tetracyclines - Chemotherapy causes intensive hydration and crytsalluria
- Cisplatin
- Methotrexate - NSAIDs cause glomerulopathy
- Due to salt retention, diuretic potency, papillary necrosis, renal vasoconstriction - Ace inhibitors cause pre-renal problems
- Due to glomerular vasodilation and filtration pressure
5
Q
Why do we not give aminoglycosides to patients with renal failure?
A
Aminoglycosides are bactericidal antibiotics which act by inhibiting bacterial protein synthesis
- Can’t give it to a patient with renal failure because of DECREASED CLEARANCE, this can lead to excess levels of drug building up and causing ototoxicity
- Ototoxicity is damage to the inner ear, resulting in damage to the organs responsible for hearing and balance. This can also be caused by loop diuretics
6
Q
Targets of diuretic drugs and mechanism of action
A
- Proximal tubule
- Carbonic anhydrase inhibitors e.g ACETAZOLAMIDE
- No Na+/H+ exchange
- Na+ stays in duct, higher solute concentration so water moves across - Ascending loop of Henle
- Loop diuretics e.g FUROSEMIDE, BUMETANIDE
- Inhibit Na/K/2Cl co-transporter
- Stop NaCl transport out of the tubule into the tissue
- Causing a decrease in Na and Cl reabsorption
- Increase in urine production
- Used in: pulmonary oedema due to left ventricular failure and also in chronic heart failure to reduce strain on heart by decreasing blood volume
- Do not use in severe hypokalaemia, hyponatraemia, anuria, renal failure and comatose states associated with liver cirrhosis
- Distal convoluted tubule
- Thiazides e.g bendroflumethiazide
- Target Na/Cl (K+) co-transporter
- Inhibit Na+ reabsorption at beginning of DCT and delivers more Na+ to the collecting duct, so retain more water
- Increases K+ loss massively, so given with K+ supplements
- Less potent than loop diuretics - Collecting tubule and duct
- ADH acts here, making aquaporins (H2O channels)
- Aldosterone agonists such as SPIRONOLACTONE
- K+ sparing diuretics
- Inhibit Na+ reabsorption through Na+ channels
- No Na/K exchange
- Glomerulus - osmotic diuresis
- Target the semipermeable membrane
- E.g MANNITOL
- Cause movement of fluid from hypo-osmotic to hyper-osmotic in glomerulus i.e from blood to urine